Keywords: teijin, chugai, develop, ipsen, drug, japan, japanese
Teijin and Chugai to develop Ipsen drug for Japan
Article | 10 September 2007
Japanese drugmakers Teijin Pharma and Chugai Pharmaceutical (a subsidiary of Switzerland's Roche) say that they have concluded a collaboration agreement ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
